Biotronik, Inc.
Clinical trials sponsored by Biotronik, Inc., explained in plain language.
-
New heart lead aims to improve pacing for slow heartbeat
Disease control CompletedThis study tests a new pacing lead (Solia CSP S) placed deep in the heart to treat slow heart rhythms. About 192 people with heart block or sinus node problems will get the lead. The main goals are to check safety (no serious device issues in 3 months) and how often the lead is p…
Phase: NA • Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Heart stent passes Real-World test: orsiro keeps arteries open
Disease control CompletedThis study looked at 556 people with coronary artery disease to confirm that the Orsiro drug-eluting stent is safe and effective in everyday use. The stent releases sirolimus to prevent artery re-narrowing. Researchers tracked how many patients had heart-related death, heart atta…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC